Evaluation of the Samsung LABGEO PT10 Hepatic Panel in a Point-of-Care Setting

Stopped early

Conditions studied: Hepatic Disease

In brief

To establish the performance characteristics of the Samsung LABGEO PT10 by comparing the test results of the PT10 Hepatic assay with results obtained from an FDA-cleared chemistry analyzer.

Key facts

Study ID

NCT02104154

Run by

Samsung Electronics

People needed

32

Starts

2013-11-01

Expected to finish

2014-09-01

Last updated by the study team

2015-02-20

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Male or female subjects with a history of elevated liver enzymes or symptoms suggestive of elevated liver enzymes
• Presenting to the site and requiring testing for levels of liver enzymes as part of routine care at the site
• Subjects able and willing to provide written informed consent

You may not qualify if…

• Subjects unable or unwilling to provide written informed consent
• Subjects with a life-threatening disease or any serious, potentially life-threatening medical illness that may compromise patient safety or study conduct

Where it is running

• Oregon Health & Science University — Portland, Oregon, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.